Rather & Kittrell’s Organon & Co OGN Stock Holding History

Rather & Kittrell’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14	Closed	–	–	225
2021 Q4	$0	Buy	+14	New	+$456	﹤0.01%	327

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rather & Kittrell's OGN Position: Q1 2022 in Review

Rather & Kittrell sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 14 shares.

Rather & Kittrell first reported a position in OGN in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

Rather & Kittrell reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
Rather & Kittrell sold 14 Organon & Co shares in Q1 2022.
Rather & Kittrell first reported a position in Organon & Co in Q4 2021 and held it in 1 quarter.
Rather & Kittrell's Organon & Co position peaked at $0 in Q4 2021.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Rather & Kittrell's 13F filing for Q1 2022, filed 10 May 2022.